(Lymphocyte-Activation Gene 3) A protein on certain cells in the immune system that controls how the cells turn on, respond, and grow. When these cells are turned on, they are more likely to attack unhealthy cells, such as cancer cells.
Clinical Trials
Merck & Co, Inc, Rahway, NJ, USA, known as MSD outside of the United States and Canada, provides international versions of this site for both healthcare professionals and the general public.
Select a language below to be redirected to the MSD version of the site in your chosen language.
By clique_admin
(Lymphocyte-Activation Gene 3) A protein on certain cells in the immune system that controls how the cells turn on, respond, and grow. When these cells are turned on, they are more likely to attack unhealthy cells, such as cancer cells.